Aksense, founded in 2017, is an innovator in the Health Care and Medical Devices sectors, with headquarters in Turkey. The company is making significant strides in the medical field with its pioneering product—an electronic biosensor aimed at Point-of-Care Testing for Infectious Diseases.
Aksense's flagship device facilitates rapid, one-minute blood tests for healthcare-associated infections, eliminating the need for a lab or expert intervention. This not only stands to save lives but also reduces time and healthcare costs, presenting a significant value proposition for healthcare providers globally.
Following a successful Seed Round investment on 09 May 2022, backed by SOSV, Aksense is well-positioned to expand its market reach and continue its development efforts. Investors should note the company's potential to disrupt traditional infection testing processes with its portable and time-efficient solution.